In cardiomyopathy, the heart becomes progressively enlarged and weak, and often arrhythmogenic, which can lead to heart failure. This common condition remains difficult to treat. The genetic contributors to cardiomyopathy are not fully recognized, although cell-cell junctions, which allow for cardiocyte communication and coordinate function, are often disrupted in the disease. Seeger et al. recently identified the protein myozap (myocardium-enriched zonula occludens-1-associated protein), which is highly expressed in the myocardium and localizes to intercalated discs at cell-cell junctions. Myozap links signaling at the intercalated disc to cardiac gene regulation by binding to a negative regulator of RhoA phosphatase, which modulates both intracellular cytoskeletal dynamics and nuclear gene transcription. Genetic knockdown of the myozap ortholog in zebrafish disrupts cardiac contractility and induces cardiomyopathy, suggesting a potential role for myozap in human heart disease.
Cardiomyopathy: myozap for the heart
Cardiomyopathy: myozap for the heart. Dis Model Mech 8 March 2010; 3 (3-4): 122. doi:
Download citation file:
Advertisement
Cited by
DMM Journal Meeting 2023: Infectious Diseases Through an Evolutionary Lens

The abstract submission deadline for our 2023 Journal Meeting ‘Infectious Diseases Through an Evolutionary Lens’ is 14 July 2023. Find out more and register here.
The Forest of Biologists

The Forest of Biologists is a biodiversity initiative created by The Company of Biologists, with support from the Woodland Trust. For every Research and Review article published in Disease Models & Mechanisms a native tree is planted in a UK forest. In addition to this we are protecting and restoring ancient woodland and are dedicating these trees to our peer reviewers. Visit our virtual forest to learn more.
Propose a new Workshop for 2025

Do you have an idea for a Workshop? If so, click here. We are now accepting proposals for our 2025 Workshops programme. As the scientific organiser, your involvement will be focused on the science. We'll take care of all the logistics. In 2025 we'll continue our efforts to diversify our Workshop programme and will be reserving one of our Workshops for an application from a Global South country to host an event overseas.
How stromal cells restrict liver cancer invasion

In our recent editor’s choice, Liqin Zhu and colleagues describe how they used in vitro liver spheroid models consisting of both parenchymal and non-parenchymal cells to reveal a hepatoprotective role for peritumoral hepatic stellate cells in liver tumorigenesis.
And from perspective… Hacking haematopoiesis – emerging tools for examining variant effects

Thousands of genomic loci have been linked to hematopoietic traits and diseases, yet many await functional validation. Michael Gundry and Vijay G. Sankaran discuss recent advances in genome editing and the challenges associated with using these techniques to assess variant function in primary hematopoietic cells. a celebration of the achievements of female scientists, and a call to action for a culture shift in science.
Other journals from
The Company of Biologists